Zejing Pharmaceuticals submits application to the Hong Kong Stock Exchange.

According to the Hong Kong Stock Exchange documents, on August 12, Suzhou Zejing Biopharmaceutical Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, with CICC as the sole sponsor.